Beloff-Chain, A., Newman, M. E., Mansford K.L.M.: In vitro studies on insulin secretion in the genetically obses mouse. Diabetologia 9: 447-452 (1973)

Beloff-Chain, A., Newman, M. E., Mansford K.L.M.: Factors influencing insulin and glucagon secretion in lean and genetically obese mice. Hormone and Metabolic Research 9: 33-37 (1977)

Newman, M.E. : Glycogen metabolism and cyclic AMP levels in isolated islets of lean and genetically obese mice. Hormone and Metabolic Research 9: 358-361 (1977)

Newman, M., McIlwain, H. : Adenosine as a constituent of the brain and of isolated cerebral tissues, and its relationship to the generation of adenosine 3’:5”-cyclic monophosphate. Biochem. J. 164: 131-137 (1977)

Newman, M.E., McIlwain, H.: Cellular site and state of combination of the adenosine 3'5'-cyclic monophosphate persisting after excitation of cerebral tissues. Biochem J. 170: 73-79 (1978)

Traversa, U., Newman, M.E.: Stereospecific influence of oxazepam hemisuccinate on cyclic AMP accumulation elicited by adenosine in cerebral cortical slices. Biochem. Pharmacol. 28: 2363-2365 (1979)

Newman, M.E., Patel, J., McIlwain, H.: The binding of 3H-adenosine to synaptosomal and other preparations from the   mammalian brain. Biochem. J. 194: 611-620 (1981)

Patel, J., Newman, M.E., McIlwain, H.: Cyclic AMP binding capabilities and histone kinase activation insubcellular components of neocortical tissue: Differential responses to three neurohumoral agents.Biochem. J. 194: 621-626  (1981)

Newman, M.E., Levitzki, A.: Characteristics of high affinity (3H)adenosine binding to rat brain synaptosomes  and   turkey erythrocyte membranes. Biochem Biophys. Acta 685: 129-136 (1982)

Newman, M.E.: Relationship of the inhibition of epinephrine -stimulated adenylate cyclase in turkey erythrocytes  by  adenosine to its "R-site" and "P-site" mediated effects.  Biochem. Pharmacol 32: 37-40 (1983)

Newman, M.E., Levitzki, A.: Desensitization of normal rat kidney (NRK) cells to adenosine. Biochem. Pharmacol. 32: 137-140 (1983)

Newman, M.E.: Adenosine binding sites in brain: Relationship to endogenous levels of adenosine and to its  physiological and regulatory roles (Commentary).  Neurochem. Int. 5: 21-26 (1983)

Newman, M.E., Klein, A., Birmaher, B., Feinsod, M.,Belmaker, R.H.: Lithium at therapeutic concentrations inhibits human brain noradrenaline-sensitive cyclic AMP accumulation.  Brain Res. 278: 380-381 (1983).

Newman, M.E., Zohar, J., Kalian, M., Belmaker, R.H.: The effects of chronic lithium and ECT on A1 and  A2 adenosine receptor systems in rat brain. Brain Res. 291: 188-192 (1984).

Klein, E., Lerer, B., Newman, M.E., Belmaker, R.H., Bhargava, H.N.: The effect of cyclo (leu-gly) on reserpine-induced hypomotility and increases in  cortical beta-adrenergic receptors.  Psychopharmacology 83: 76-78 (1984)

Shapira, B., Zohar, J., Newman, M., Drexler, H., Belmaker, R.H.: Potentiation of seizure length and clinical response to electroconvulsive therapy by caffeine pretreatment: a case report. Convulsive Therapy 1: 58-60 (1985)

Newman, M.E.: Adenosine-homocysteine interactions in controlling cyclic AMP in rat brain cortical slices. Biochem. Pharmacol. 34: 1435-1438 (1985)

Hamburger, R., Newman, M.E.: Effects of vasopressin on noradrenalin induced cyclic AMP accumulation in rat brain slices. Pharmacol. Biochem. Behav. 22: 183-187 (1985).

Newman, M.E., Lichtenberg, P., Belmaker, R.H.: Effects of lithium in vitro on noradrenaline-induced cyclic AMP accumulation in  rat cortical slices after reserpine-induced supersensitivity. Neuropharmacology 24:353-355  (1985)

Newman, M.E.: Vasopressin inhibits cyclic AMP accumulation and adenylate cyclase activity in cerebral preparations. FEBS Letters 181: 203-206 (1985)

Newman, M.E., Hamburger, R.: Vasopressin inhibition of cyclic AMP accumulation and effects on the learned response in inbred mouse  strains. Life Sciences 37: 2037-2042 (1985)

Hamburger, R., Robert, M., Newman, M.E, Belmaker, R.H.: Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMP. Pharmacol. Biochem. Behav. 24: 9-13 (1986)

Newman, M.E., Solomon, H., Lerer, B.: Electroconvulsive shock and cyclic AMP signal transduction:effects distal to  the receptor. J. Neurochem. 46: 1667-1669 (1986)

Newman, M.E and Belmaker, R.H.: Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in rat cerebral cortex membranes. Neuropharmacology 26: 211-217  (1987).

Newman, M.E., Lipot, M., Lerer, B.: Differential effects of chronic desipramine administration on the cyclic AMP response in rat cortical slices and membranes. Neuropharmacology 26: 1127‑1130 (1987).

Newman, M.E., Miskin, I., Lerer, B.: Effects of single and repeated electroconvulsive shock administration on inositol  phosphate accumulation in rat brain slices. J. Neurochem. 49: 19‑23 (1987).

Newman, M.E. and Lerer, B.: Effects of lithium and desipramine administration on inositol phosphate accumulation in rat cerebral cortex. Biochem. Pharmacol. 37: 1991‑1995 (1988).

Newman, M.E. and Lerer, B.: Chronic electroconvulsive shock and desipramine  reduce the degree of inhibition by 5‑HT and carbachol of forskolin‑stimulated adenylate cyclase in rat hippocampal membranes. Eur. J.Pharmacol. 148: 257‑260 (1988).

:

Ebstein RP, Lerer B, Bennett ER, Dayek DB, Newman ME, Shapira B, Kindler S.  Second messenger function in lymphocytes and platelets: a comparison of peripheral and central mechanisms.  Clin Neuropharmacol. 1986;9 Suppl 4:350-2

Newman, M.E. and Lerer, B.: Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: Relevance to mechanism of action of electroconvulsive therapy and antidepressants. Prog. Neuropsychopharmacol. Biol. Psych. 13: 1-30 (1989).

Newman, M.E. and Lerer, B.: Post‑receptor mediated increases in adenylate cyclase activity after chronic antidepressant treatment: Relationship to receptor desensitisation. Eur. J. Pharmacol.162: 345-352 (1989).

Newman, M.E. and Lerer, B.: Effects of chronic ECS on D1 and D2 dopamine receptor‑mediated adenylate cyclase  activity in rat striatal and limbic forebrain homogenates   Neuropharmacology 28: 787-790 (1989).

Newman, M.E., Drummer, D., Lerer, B.: Single and  combined effects of desipramine and  lithium on serotonergic receptor number and second messenger function in rat brain.  J.  Pharmacol. Exptl. Ther. 252: 826-238  (1990).

Shoham, S., Newman, M.E., Wurtman, E. and Ebstein, R.P.: Cholinergic second messenger systems after  nucleus  basalis lesions in rat brain: Presynaptic deficit correlates with memory loss. Pharmacol. Biochem. Behav. 36: 507- 513 (1990).

Kofman, O., Klein, E., Newman., M.E., Hamburger, R., Kimche,O., Nir, T., Shimon, H., Belmaker, R.H. Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate  cyclase and amphetamine-induced hyperactivity. Pharmacol. Biochem. Behav. 37: 417-424  (1990)

Newman, M.E., Lerer, B.: 5HT-1A receptor-mediated effects of antidepressants: Relation to G  protein function. Clin Neuropharmacol. 13: (Suppl. 2) 237-238 (1990).

Belmaker, R.H., Lerer, B., Newman, M.E., Fuchs, I.: Lack of effect of lithium, propranolol or haloperidol on basal plasma cyclic AMP levels. Lithium, 2: 115-116 (1991)

Newman, M.E.: Lithium and the phosphoinositide hydrolysis second messenger system: a critical review of its therapeutic relevance. Lithium, 2: 187-194 (1991)

Newman, M.E., Ben-Zeev, A., Lerer, B.: Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate  cyclase in rat hippocampus. Eur. J.Pharmacol.,   207: 209-213 (1991)

Newman, M.E., Shapira, B., Lerer, B.: Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects. Neuropharmacology,  30: 1297-1301 (1991)

Rogel-Fuchs, Y., Newman, M.E., Trombka, D., Zahalka, E.A.,Yanai, J.: Hippocampal cholinergic alterations and related behavioral deficits after early exposure to phenobarbital.  Brain Res. Bulletin, 29: 1-6 (1992)

Newman, M.E., Shapira, B., Lerer, B.: Regulation of 5-HT-1a receptor function in rat hippocampus by short- and long-term administration of 5-HT-1a agonists and antidepressants. J. Pharmacol. Exptl. Ther., 260: 16-20 (1992)

Shapira, B., Yagmur, M., Gropp, C., Newman, M.E., Lerer, B.: Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression. Biol. Psychiat., 31: 975-983 (1992)

Newman, M.E.: Serotonin inhibits adenylate cyclase in human platelet membranes. Eur.J. Pharmacol. 226: 281-285 (1992)

Newman, M. E., Lerer, B., Lichtenberg, P., Shapira, B.: Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology, 109: 231-234 (1992)

Lichtenberg, P., Shapira, B., Gillon, D., Kindler, S., Cooper, T.B., Newman, M.E., Lerer, B.:Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Research, 43: 137-146 (1992)

Shapira, B., Newman, M.E., Lerer, B.: Serotonergic mechanisms of ECT: Neuroendocrine evidence. Clin. Neuropharmacol. 15: (Suppl. 1) 673A-674A (1992)

Yanai, J., Rogel-Fuchs, Y., Pick, C.G., Slotkin, T., Seidler, F.J., Zahalka, E.A., Newman, M.E.: Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways.  Neuropharmacology, 32: 113-118 (1993)

Newman, M. E., Lerer, B., Shapira, B.: 5-HT-1a receptor-mediated effects of antidepressants.  Prog. Neuropsychopharmacol. Biol. Psychiat., 17: 1-19 (1993)

Shapira, B., Cohen, J., Newman, M.E., Lerer, B.: Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients. Biol. Psychiat., 33: 531-535 (1993)

Shapira, B., Newman, M.E., Lerer, B.: Serotonergic mechanisms in depression: clinical insights and biological correlates. Israel J. Med. Sci., 30: 162-167 (1994)

Weizman, R., Gur, E., Laor, N., Reiss, A., Muller, U., Yoresh, A., Lerer, B., Newman, M.E.: Platelet adenylate cyclase activity in Israeli victims of Iraqi Scud missile attacks with post traumatic  stress disorder. Psychopharmacology, 114: 509-512 (1994)

Gur, E., Rogel-Fuchs, Y., Newman, M.E., Lerer, B.: Effects of antidepressants on cyclic AMP responses in the living rat. Eur. Neuropsychopharmacol. 4: 317 (1994)

Segman, R., Newman, M.E., Lerer, B.: Serotonin stimulation of GTP binding in rat hippocampal membranes and the action of antidepressant drugs. Eur. Neuropsychopharmacol.  4: 318 (1994)

Newman, M.E.: Serotonin inhibition of adenylate cyclase in human platelet membranes; relation to 5-HT-1a receptor -mediated activity. Biochem.Pharmacol., 48: 1677-1682 (1994)

Lesch, K.P., Stober, G., Balling, U., Franzek, E., Li, S.H., Ross, C., Newman, M.E.,  Beckmann, H.  Riederer, P.(1994) Triplet repeats in clinical subtypes of schizophrenia: variation at  the DRPLA (B37 CAG repeat) locus is not associated with periodic catatonia. J. Neural Transm. 98: 153-158 (1994)

Kohn, Y., Newman, M.E., Lerer, B., Orr, S.P., Pitman, R.K.: Absence of reduced platelet adenylate cyclase activity in Vietnam veterans with PTSD. Biol. Psychiat., 37: 205-208 (1995)

Zahalka, E.A., Rehavi, M., Newman, M.E., Yanai, J.:  Alterations in hippocampal hemicholium-3 binding and related  behavioural and biochemical changes after prenatal  phenobarbital exposure. Psychopharmacology, 122: 44-50 (1995)

Gur, E., Lerer, B., Newman, M.E.: Acute or chronic lithium does not affect agonist-stimulated inositol  trisphosphate formation in rat brain in vivo. NeuroReport, 7: 393-396  (1996)

Abu-Roumi, M., Newman, M.E., Yanai, J.: Inositol phosphate formation in mice prenatally exposed to drugs:  relation to muscarinic receptors and post-receptor effects.  Brain Res. Bulletin, 40: 183-186 (1996)

Gur, E., Berman, E., Lerer, B., Newman, M.E.: In vivo cyclic AMP responses in rat brain are not modified by chronic electroconvulsive shock. Eur. Neuropsychopharmacol., 7: 189-193 (1997)

Gur, E., Lerer, B., Newman, M.E.: Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain; an in vivo microdialysis study. J. Neural Transm., 104: 795-804 (1997)

Newman, M.E., Gur, E., Shapira, B., Lerer, B.: Neurochemical mechanisms of action of ECS: evidence from in vivo studies. Journal of ECT Research, 14: 153-171 (1998)

Newman, M.E., Shapira, B., Lerer, B.: Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. Int. J. Neuropsychopharmacol., 1: 49-69 (1998)

Feldman, S., Newman, M.E., Weidenfeld, J.: Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses. NeuroReport 9: 2007-2009 (1998)

Newman, M.E.: The need for cautiously extrapolating results obtained with normal animals (healthy individuals) to depressed ones (Matters Arising-letter). J. Neurochem. 70: 2641 (1998)

Gur, E., Lerer, B., Newman, M.E.: Chronic clomipramine and triiodothyronine increase 5 HT levels in rat frontal cortex in vivo: relationship to 5-HT autoreceptor activity. J Pharmacol. Exp. Ther. 288: 81-87 (1999)

Lerer B., Gelfin Y., Gorfine M., Allolio B., Lesch K.P., Newman M.E:. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology, 20: 628-639 (1999)

Gur, E., Dremencov, E., Lerer, B., Newman, M.E.: Venlafaxine: acute and chronic effects on 5-HT levels in rat brain in vivo. Eur. J. Pharmacol., 372: 17-24 (1999)

Newman, M.E., Gelfin, Y., Li, Q., Van de Kar, L.D., Lerer, B.: Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects. Psychopharmacology, 145: 99-104 (1999)

Dremencov, E., Gur, E.,  Lerer, B., Newman, M.E: Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis. Eur. Neuropsychopharmacol., 10: 229-236 (2000)

Shapira, B., Newman, M.E., Gelfin, Y., Lerer, B. :Blunted temperature and hormone responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy.  Psychoneuroendocrinology, 25: 421-438 (2000).

Newman, M.E., Agid, O. Gur, E., Lerer, B. Pharmacological mechanisms of T3 augmentation of antidepressant action. Int. J. Neuropsychopharmacol., 3: 187-191 (2000)

Feldman, S., Newman, M.E., Weidenfeld, J. Effects of adrenergic and serotonergic agonists in the amygdala on the hypothalamo-pituitary-adrenocortical axis. Brain Res. Bulletin, 52: 531-536 (2000)

Gur, E., Lerer, B., Dremencov, E., Newman, M.E.: Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport, 11: 2925-2929 (2000).

Newman, M.E., Gur, E., Dremencov, E., Garcia, F., Lerer, B., van de Kar, L.D.: Chronic clomipramine alters presynaptic 5-HT1B  and postsynaptic 5-HT1A receptor sensitivity in rat hypothalamus and hippocampus respectively. Neuropharmacology, 39: 2309-2317 (2000)

Steingart, R.A., Abu-Roumi , M., Newman, M.E., Silverman, W.F., Slotkin, T.A., Yanai, J. Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: cellular mechanisms and the reversal of deficits by neural grafts. Brain Research Dev. Brain Res. 30: 125-133 (2000)

Gur, E., Dremencov, E., Lerer, B., Newman, M.E.: Functional  effects  of  corticosterone  on 5-HT1A  and  5-HT1B  receptor  activity  in  rat  brain: in  vivo  microdialysis  studies. Eur. J. Pharmacol., 411: 115-122 (2001)

Gur, E., Dremencov, E., van de Kar, L.D., Lerer, B., Newman, M.E.: Effects of chronically administered venlafaxine on serotonin receptor activity in rat hippocampus and hypothalamus. Eur. J. Pharmacol., 436: 57-65 (2002)

Weidenfeld, J., Feldman, S., Itzik, A., van de Kar, L.D., Newman, M.E. : Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and corticosterone secretion in the rat. Brain Res., 941: 113-117 (2002)

Gur, E., Dremencov, E., Garcia, F., van de Kar, L.D., Lerer, B., Newman, M.E.: Functional  effects  of  chronic  electroconvulsive  shock  on  serotonergic 5-HT1A  and  5-HT1B  receptor  activity  in  rat  hippocampus and  hypothalamus. Brain Res., 952: 52-60 (2002)

Dremencov, E., Gur, E., Lerer, B., Newman, M.E.: Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Prog. Neuropsychopharmacol. Biol. Psychiat., 26: 1029-1034 (2002)

Weidenfeld, J., Newman, M.E., Itzik A., Gur, E., Feldman, S.: The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic 5-HT following electrical stimulation of the dorsal raphe nuclei in the rat. Neuroendocrinology, 76: 63-69 (2002)

Gur, E., Lifschytz, T., Lerer, B., Newman, M.E.: Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT1 autoreceptor activity in rat cortex. Eur. J. Pharmacol., 457: 37-43 (2002)

Gur, E., Lerer, B., Van de Kar, L.D., Newman, M.E.: Chronic rTMS induces subsensitivity of post-synaptic 5-HT1A receptors in rat hypothalamus. Submitted

Gur, E., Lifschytz, T., Van de Kar, L.D., Lerer, B., Newman, M.E.: Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus. Submitted

Dremencov, E., Gur, E., Lerer, B., Newman, M.E.: Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiat.,

Gur, E., Newman, M.E., Avraham, Y., Dremencov, E., Berry, E.M.: The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats. Nutr. Neurosci., in press

Book Chapters

Newman, M.E., Patel J.: Protein binding of cyclic AMP in interpretation of its role in neural conduction. In: Chemisms of the Brain, eds. R. Rodnight, H.S. Bachelard, W.L. Stahl, Churchill Livingstone, pp. 130-135 (1981)

Newman, M.E.: Modulation of adenylate cyclase by physiological and pharmacological manipulation of the prevalent adenosine concentration. In: Purines: Pharmacology and Physiological Roles, ed. T.W.Stone, MacMillan, pp. 185-192 (1985)

Newman, M.E., Belmaker, R.H., Hamburger-Bar R., Lerer, B.: Receptor-mediated and –independent effects in the actions of lithium and electroconvulsive shock on adenylate cyclase. In: Drug Receptors and Dynamic Processes in Cells, eds. J.S.Schou, A. Geisler, S. Norn, Munksgaard, pp 290-301 (1986).

Newman, M.E., Lerer, B.: Changes in rat brain second messenger function on administration of psychoactive drugs: relationship to receptor number and desensitization. In: Progress in Catecholamine Research, Part B: Central aspects, eds. M.Sandler, A. Dahlstrom, R.H. Belmaker, A.R. Liss Inc. pp 389-395 (1988)

Lerer, B., Gur, E., Bleich, A., Newman, M.E.: Peripheral adrenergic receptors in PTSD. In: Catecholamine Function in Posttraumatic Stress Disorder, ed. M. Murburg, American Psychiatric Press, pp. 257-276 (1994)

Yirmiya, R., Pollak, Y., Morag, M., Reichenberg, A., Barak, O., Avitsur, R., Shavit, Y., Ovadia, H., Weidenfeld, J., Morag, A., Newman, M.E., Pollmacher, T.: Illness, Cytokines and Depression. In: Annals of the New York Academy of Sciences, Vol. 917, pp. 478-487 (2000)

Newman, M.E., Lerer, B.: Neurotransmitters and second messengers. In: New Oxford Textbook of Psychiatry, eds. M.G. Gelder, J.J. Lopez-Ibor, N.C. Andreasen, Oxford University Press, Vol. 1 pp. 188-197 (2001)